Nantahala Capital Management, LLC 13D/13G Filings for Akebia Therapeutics, Inc. (AKBA)

Nantahala Capital Management, LLC 13D and 13G filings for Akebia Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
06:42 am
Purchase
2020-12-31 13G Akebia Therapeutics, Inc.
AKBA
Nantahala Capital Management, LLC 7,040,487
4.900%
303,367increase
(+4.50%)
Filing